PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Genomic Medicine Institute, Lerner Research Institute, Cleveland Clinic, Cleveland, Ohio 44195, United States.\', \'Department of Molecular Medicine, Cleveland Clinic Lerner College of Medicine, Case Western Reserve University, Cleveland, Ohio 44195, United States.\', \'Case Comprehensive Cancer Center, Case Western Reserve University School of Medicine, Cleveland, Ohio 44106, United States.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1021/acs.jproteome.0c00397
?:doi
?:hasPublicationType
?:journal
  • Journal of proteome research
is ?:pmid of
?:pmid
?:pmid
  • 32907334
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.818
?:rankingScore_hIndex
  • 140
is ?:relation_isRelatedTo_publication of
?:title
  • Repurposing of FDA-Approved Toremifene to Treat COVID-19 by Blocking the Spike Glycoprotein and NSP14 of SARS-CoV-2.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all